Engineered virus-mimicking nanovaccine with lymph node–tumor dual-targeting and STING-activating capacity for robust cancer immunotherapy

Update your browser to view ScienceDirect correctly.

Your technical details and browser version:

Request ID: 8f6289a03a42944d-LAX IP: 116.62.10.13 UTC time: 2024-12-22T19:32:23+00:00 Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

留言 (0)

沒有登入
gif